{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:53:47Z","timestamp":1788587627499,"version":"build-2803163510"},"reference-count":206,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes &amp; Diseases"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.gendis.2021.10.009","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T23:38:19Z","timestamp":1638488299000},"page":"849-867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["MicroRNAs and JAK\/STAT3 signaling: A new promising therapeutic axis in blood cancers"],"prefix":"10.1016","volume":"9","author":[{"given":"Mehdi","family":"Sajjadi-Dokht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talar Ahmad","family":"Merza Mohamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heshu","family":"Sulaiman Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwah","family":"Suliman Maashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Danshina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navid","family":"Shomali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Solali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faroogh","family":"Marofi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Zeinalzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morteza","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Adili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Aslaminabad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Farshdousti Hagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Jarahian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0268-960X(03)00040-7","article-title":"Cytogenetics in acute leukemia","volume":"18","author":"Mr\u00f3zek","year":"2004","journal-title":"Blood Rev"},{"issue":"12","key":"10.1016\/j.gendis.2021.10.009_bib2","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1038\/s41375-020-0872-3","article-title":"Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years","volume":"34","author":"Eisfeld","year":"2020","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.gendis.2021.10.009_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/blood.2019000937","article-title":"Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA)","volume":"136","author":"Brown","year":"2020","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.gendis.2021.10.009_bib4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/cas.12655","article-title":"Targeting the canonical Wnt\/\u03b2-catenin pathway in hematological malignancies","volume":"106","author":"Ashihara","year":"2015","journal-title":"Cancer Sci"},{"key":"10.1016\/j.gendis.2021.10.009_bib5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fonc.2014.00108","article-title":"Targeting the PI3K\/mTOR pathway in pediatric hematologic malignancies","volume":"4","author":"Tasian","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.gendis.2021.10.009_bib6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1756-8722-3-33","article-title":"Role of Wnt canonical pathway in hematological malignancies","volume":"3","author":"Ge","year":"2010","journal-title":"J Hematol Oncol"},{"issue":"21","key":"10.1016\/j.gendis.2021.10.009_bib7","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/onc.2012.347","article-title":"JAK\/STAT signaling in hematological malignancies","volume":"32","author":"Vainchenker","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.gendis.2021.10.009_bib8","doi-asserted-by":"crossref","first-page":"106210","DOI":"10.1016\/j.intimp.2020.106210","article-title":"The role of JAK\/STAT signaling pathway and its inhibitors in diseases","volume":"80","author":"Xin","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.gendis.2021.10.009_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cyto.2016.06.017","article-title":"JAK-STAT signaling in cancer: from cytokines to non-coding genome","volume":"87","author":"Pencik","year":"2016","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.gendis.2021.10.009_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ccell.2017.11.009","article-title":"Dual targeting of oncogenic activation and inflammatory signaling increases therapeutic efficacy in myeloproliferative neoplasms","volume":"33","author":"Kleppe","year":"2018","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3390\/ijms22020603","article-title":"The multifaced role of STAT3 in cancer and its implication for anticancer therapy","volume":"22","author":"Tolomeo","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.gendis.2021.10.009_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.tibs.2007.12.002","article-title":"Mining for JAK\u2013STAT mutations in cancer","volume":"33","author":"Constantinescu","year":"2008","journal-title":"Trends Biochem Sci"},{"issue":"9","key":"10.1016\/j.gendis.2021.10.009_bib13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3390\/cancers10090327","article-title":"The role of signal transducer and activator of transcription 3 (STAT3) and its targeted inhibition in hematological malignancies","volume":"10","author":"Arora","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib14","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1159\/000487172","article-title":"Serine\/threonine kinase 35, a target gene of STAT3, regulates the proliferation and apoptosis of osteosarcoma cells","volume":"45","author":"Wu","year":"2018","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"10.1016\/j.gendis.2021.10.009_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.14735\/amko202032","article-title":"The important role of STAT3 in chronic lymphocytic leukaemia biology","volume":"33","author":"Boudny","year":"2020","journal-title":"Klin Onkol"},{"issue":"5","key":"10.1016\/j.gendis.2021.10.009_bib16","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/s41375-017-0004-x","article-title":"Oncogenic activation of JAK3-STAT signaling confers clinical sensitivity to PRN371, a novel selective and potent JAK3 inhibitor, in natural killer\/T-cell lymphoma","volume":"32","author":"Nairism\u00e4gi","year":"2018","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.gendis.2021.10.009_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/bjc.2015.233","article-title":"The role of JAK\/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours","volume":"113","author":"Thomas","year":"2015","journal-title":"Br J Cancer"},{"issue":"6","key":"10.1016\/j.gendis.2021.10.009_bib18","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3390\/cells9061451","article-title":"Targeting the JAK\/STAT signaling pathway using phytocompounds for cancer prevention and therapy","volume":"9","author":"Bose","year":"2020","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.gendis.2021.10.009_bib19","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1182\/blood-2002-04-1204","article-title":"Signal transducer and activator of transcription proteins in leukemias","volume":"101","author":"Benekli","year":"2003","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib20","doi-asserted-by":"crossref","first-page":"824","DOI":"10.7150\/thno.49600","article-title":"A novel STAT3 inhibitor W2014-S regresses human non-small cell lung cancer xenografts and sensitizes EGFR-TKI acquired resistance","volume":"11","author":"Zheng","year":"2021","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.gendis.2021.10.009_bib21","article-title":"Signal transducer and activator of transcription\u20133 induces microRNA-155 expression in chronic lymphocytic leukemia","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"issue":"57","key":"10.1016\/j.gendis.2021.10.009_bib22","doi-asserted-by":"crossref","first-page":"97516","DOI":"10.18632\/oncotarget.22178","article-title":"Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK\/STAT3 signaling","volume":"8","author":"Kuusanm\u00e4ki","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1021\/acschembio.5b00945","article-title":"Strategies and approaches of targeting STAT3 for cancer treatment","volume":"11","author":"Furtek","year":"2016","journal-title":"ACS Chem Biol"},{"issue":"1","key":"10.1016\/j.gendis.2021.10.009_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12943-020-01258-7","article-title":"Targeting STAT3 in cancer immunotherapy","volume":"19","author":"Zou","year":"2020","journal-title":"Mol Cancer"},{"issue":"24","key":"10.1016\/j.gendis.2021.10.009_bib25","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1152\/physiolgenomics.00122.2013","article-title":"Interplay between microRNAs and the STAT3 signaling pathway in human cancers","volume":"45","author":"Cao","year":"2013","journal-title":"Physiol Genomics"},{"issue":"3","key":"10.1016\/j.gendis.2021.10.009_bib26","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3727\/096504018X15247361080118","article-title":"MicroRNA-411 inhibits cervical cancer progression by directly targeting STAT3","volume":"27","author":"Shan","year":"2019","journal-title":"Oncol Res"},{"issue":"3","key":"10.1016\/j.gendis.2021.10.009_bib27","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3892\/or.2015.4524","article-title":"MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3","volume":"35","author":"Xu","year":"2016","journal-title":"Oncol Rep"},{"key":"10.1016\/j.gendis.2021.10.009_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s11658-020-00207-y","article-title":"MicroRNA-125b exerts antitumor functions in cutaneous squamous cell carcinoma by targeting the STAT3 pathway","volume":"25","author":"Tian","year":"2020","journal-title":"Cell Mol Biol Lett"},{"issue":"4","key":"10.1016\/j.gendis.2021.10.009_bib29","first-page":"2527","article-title":"MicroRNA-449b-3p inhibits epithelial-mesenchymal transition by targeting IL-6 and through the JAK2\/STAT3 signaling pathway in non-small cell lung cancer","volume":"19","author":"Cai","year":"2020","journal-title":"Exp Ther Med"},{"issue":"1","key":"10.1016\/j.gendis.2021.10.009_bib30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/hep.25632","article-title":"Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha","volume":"56","author":"Wang","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.gendis.2021.10.009_bib31","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.omtn.2019.12.020","article-title":"Inhibition of CRY2 by STAT3\/miRNA-7-5p promotes osteoblast differentiation through upregulation of CLOCK\/BMAL1\/P300 expression","volume":"19","author":"Tang","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"issue":"4","key":"10.1016\/j.gendis.2021.10.009_bib32","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/ibd\/izz281","article-title":"miR-29a-5p\/STAT3 positive feedback loop regulates TETs in colitis-associated colorectal cancer","volume":"26","author":"Wang","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.gendis.2021.10.009_bib33","doi-asserted-by":"crossref","first-page":"113961","DOI":"10.1016\/j.envpol.2020.113961","article-title":"microRNAs expression in relation to particulate matter exposure: a systematic review","volume":"260","author":"Cheng","year":"2020","journal-title":"Environ Pollut"},{"issue":"3","key":"10.1016\/j.gendis.2021.10.009_bib34","doi-asserted-by":"crossref","first-page":"100844","DOI":"10.1016\/j.genrep.2020.100844","article-title":"Dysregulation of miR-27a and SMAD2 can be a reliable indicator in the prognosis and diagnosis of CRC as well as in response to chemotherapy drugs","volume":"21","author":"Azar","year":"2020","journal-title":"Gene Rep"},{"key":"10.1016\/j.gendis.2021.10.009_bib35","doi-asserted-by":"crossref","first-page":"107355","DOI":"10.1016\/j.intimp.2020.107355","article-title":"miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4","volume":"92","author":"Azar","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.gendis.2021.10.009_bib36","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000445625","article-title":"MiR-410 down-regulates the expression of interleukin-10 by targeting STAT3 in the pathogenesis of systemic lupus erythematosus","volume":"39","author":"Liu","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.gendis.2021.10.009_bib37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.omtn.2020.10.030","article-title":"Biological implications and clinical potential of metastasis-related miRNA in colorectal cancer","volume":"23","author":"Niu","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"issue":"14","key":"10.1016\/j.gendis.2021.10.009_bib38","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.7150\/ijbs.47203","article-title":"miRNA-based biomarkers, therapies, and resistance in cancer","volume":"16","author":"He","year":"2020","journal-title":"Int J Biol Sci"},{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib39","doi-asserted-by":"crossref","first-page":"e1563","DOI":"10.1002\/wrna.1563","article-title":"Cluster miRNAs and cancer: diagnostic, prognostic and therapeutic opportunities","volume":"11","author":"Kabekkodu","year":"2020","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"1","key":"10.1016\/j.gendis.2021.10.009_bib40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12029-019-00356-0","article-title":"Prognostic and diagnostic values of miR-506 and SPON 1 in colorectal cancer with clinicopathological considerations","volume":"52","author":"Tamjidifar","year":"2021","journal-title":"J Gastrointest Cancer"},{"issue":"3","key":"10.1016\/j.gendis.2021.10.009_bib41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1158\/2159-8290.CD-15-0893","article-title":"miRNA deregulation in cancer cells and the tumor microenvironment","volume":"6","author":"Rupaimoole","year":"2016","journal-title":"Cancer Discov"},{"issue":"4","key":"10.1016\/j.gendis.2021.10.009_bib42","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00109-014-1129-2","article-title":"MicroRNAs: master regulators of drug resistance, stemness, and metastasis","volume":"92","author":"Raza","year":"2014","journal-title":"J Mol Med (Berl)"},{"issue":"9","key":"10.1016\/j.gendis.2021.10.009_bib43","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/iub.2345","article-title":"miR-143 acts as an inhibitor of migration and proliferation as well as an inducer of apoptosis in melanoma cancer cells in\u00a0vitro","volume":"72","author":"Nabipoorashrafi","year":"2020","journal-title":"IUBMB Life"},{"issue":"13","key":"10.1016\/j.gendis.2021.10.009_bib44","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/cvr\/cvz315","article-title":"STAT3-miR-17\/20 signalling axis plays a critical role in attenuating myocardial infarction following rapamycin treatment in diabetic mice","volume":"116","author":"Samidurai","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.gendis.2021.10.009_bib45","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3389\/fonc.2020.01713","article-title":"A positive feedback loop of lncRNA DSCR8\/miR-98-5p\/STAT3\/HIF-1\u03b1 plays a role in the progression of ovarian cancer","volume":"10","author":"Dong","year":"2020","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.gendis.2021.10.009_bib46","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.7150\/thno.48761","article-title":"M2 microglial small extracellular vesicles reduce glial scar formation via the miR-124\/STAT3 pathway after ischemic stroke in mice","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.gendis.2021.10.009_bib47","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2147\/NDT.S251152","article-title":"MiRNA-532-5p regulates CUMS-induced depression-like behaviors and modulates LPS-induced proinflammatory cytokine signaling by targeting STAT3","volume":"16","author":"Yan","year":"2020","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"6","key":"10.1016\/j.gendis.2021.10.009_bib48","first-page":"3064","article-title":"Overexpression of IL-9 induced by STAT3 phosphorylation is mediated by miR-155 and miR-21 in chronic lymphocytic leukemia","volume":"39","author":"Chen","year":"2018","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.gendis.2021.10.009_bib49","doi-asserted-by":"crossref","first-page":"12262","DOI":"10.1038\/s41598-017-12135-7","article-title":"Microenvironment regulates the expression of miR-21 and tumor suppressor genes PTEN, PIAS3 and PDCD4 through ZAP-70 in chronic lymphocytic leukemia","volume":"7","author":"Carabia","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.gendis.2021.10.009_bib50","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1365-2567.2009.03114.x","article-title":"Th9 and allergic disease","volume":"127","author":"Soroosh","year":"2009","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.gendis.2021.10.009_bib51","first-page":"319","article-title":"Interleukin-9 and mast cells","volume":"26","author":"Tete","year":"2012","journal-title":"J Biol Regul Homeost Agents"},{"issue":"11","key":"10.1016\/j.gendis.2021.10.009_bib52","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1074\/jbc.M807531200","article-title":"Acute lymphoblastic leukemia-associated JAK1 mutants activate the Janus kinase\/STAT pathway via interleukin-9 receptor alpha homodimers","volume":"284","author":"Hornakova","year":"2009","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib53","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/ijc.26471","article-title":"Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes","volume":"131","author":"Carretero","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.gendis.2021.10.009_bib54","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1756-8722-5-43","article-title":"Splenomegaly in myelofibrosis\u2014new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors","volume":"5","author":"Randhawa","year":"2012","journal-title":"J Hematol Oncol"},{"issue":"16","key":"10.1016\/j.gendis.2021.10.009_bib55","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1182\/blood-2014-10-606038","article-title":"Three-year follow-up of treatment-na\u00efve and previously treated patients with CLL and SLL receiving single-agent ibrutinib","volume":"125","author":"Byrd","year":"2015","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.gendis.2021.10.009_bib56","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia","volume":"353","author":"Calin","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib57","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/leu.2016.181","article-title":"Ibrutinib downregulates a subset of miRNA leading to upregulation of tumor suppressors and inhibition of cell proliferation in chronic lymphocytic leukemia","volume":"31","author":"Saleh","year":"2017","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.gendis.2021.10.009_bib58","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood-2010-01-263889","article-title":"microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival","volume":"116","author":"Rossi","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.gendis.2021.10.009_bib59","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1365-2362.2011.02535.x","article-title":"Prognostic role of microRNA-21 in various carcinomas: a systematic review and meta-analysis","volume":"41","author":"Fu","year":"2011","journal-title":"Eur J Clin Invest"},{"issue":"8","key":"10.1016\/j.gendis.2021.10.009_bib60","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2174\/138945010791591403","article-title":"MicroRNA-21: from cancer to cardiovascular disease","volume":"11","author":"Jazbutyte","year":"2010","journal-title":"Curr Drug Targets"},{"issue":"4","key":"10.1016\/j.gendis.2021.10.009_bib61","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1021\/pr201079y","article-title":"Identification of novel miR-21 target proteins in multiple myeloma cells by quantitative proteomics","volume":"11","author":"Xiong","year":"2012","journal-title":"J Proteome Res"},{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib62","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1074\/jbc.M707224200","article-title":"Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells","volume":"283","author":"Frankel","year":"2008","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.gendis.2021.10.009_bib63","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1093\/nar\/gkp117","article-title":"Estradiol downregulates miR-21 expression and increases miR-21 target gene expression in MCF-7 breast cancer cells","volume":"37","author":"Wickramasinghe","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.gendis.2021.10.009_bib64","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood-2007-03-081133","article-title":"Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer","volume":"110","author":"L\u00f6ffler","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.gendis.2021.10.009_bib65","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cytogfr.2011.05.002","article-title":"Role of microRNA-155 in autoimmunity","volume":"22","author":"Leng","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"issue":"18","key":"10.1016\/j.gendis.2021.10.009_bib66","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1073\/pnas.0602266103","article-title":"Pre-B cell proliferation and lymphoblastic leukemia\/high-grade lymphoma in E(mu)-miR155 transgenic mice","volume":"103","author":"Costinean","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5824","key":"10.1016\/j.gendis.2021.10.009_bib67","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1126\/science.1141229","article-title":"Regulation of the germinal center response by microRNA-155","volume":"316","author":"Thai","year":"2007","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.gendis.2021.10.009_bib68","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0008-8749(02)00506-3","article-title":"T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC","volume":"217","author":"Haasch","year":"2002","journal-title":"Cell Immunol"},{"issue":"10","key":"10.1016\/j.gendis.2021.10.009_bib69","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1073\/pnas.0500613102","article-title":"Accumulation of miR-155 and BIC RNA in human B cell lymphomas","volume":"102","author":"Eis","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.gendis.2021.10.009_bib70","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2006-12-062398","article-title":"Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia","volume":"109","author":"Fulci","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib71","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/path.1825","article-title":"BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas","volume":"207","author":"Kluiver","year":"2005","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib72","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/gcc.10316","article-title":"High expression of precursor microRNA-155\/BIC RNA in children with Burkitt lymphoma","volume":"39","author":"Metzler","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"issue":"14","key":"10.1016\/j.gendis.2021.10.009_bib73","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1182\/blood-2009-10-230060","article-title":"STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells","volume":"115","author":"Hazan-Halevy","year":"2010","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.gendis.2021.10.009_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011859","article-title":"Stat3 activates the receptor tyrosine kinase like orphan receptor-1 gene in chronic lymphocytic leukemia cells","volume":"5","author":"Li","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.gendis.2021.10.009_bib75","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2407-11-33","article-title":"MicroRNA-34a is a potent tumor suppressor molecule in\u00a0vivo in neuroblastoma","volume":"11","author":"Tivnan","year":"2011","journal-title":"BMC Cancer"},{"issue":"14","key":"10.1016\/j.gendis.2021.10.009_bib76","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1182\/blood-2010-05-285064","article-title":"MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia","volume":"117","author":"Vargova","year":"2011","journal-title":"Blood"},{"issue":"5573","key":"10.1016\/j.gendis.2021.10.009_bib77","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1071545","article-title":"A road map for those who don't know JAK-STAT","volume":"296","author":"Aaronson","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.gendis.2021.10.009_bib78","first-page":"31","article-title":"Acute lymphocytic leukemia in adults. Pathologic features and prognosis","volume":"53","author":"Marinescu","year":"2015","journal-title":"Rom J Intern Med"},{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib79","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","article-title":"A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study","volume":"10","author":"Den Boer","year":"2009","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.gendis.2021.10.009_bib80","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/bjh.14953","article-title":"The presence of Philadelphia chromosome does not confer poor prognosis in adult pre-B acute lymphoblastic leukaemia in the tyrosine kinase inhibitor era \u2013 a surveillance, epidemiology, and end results database analysis","volume":"179","author":"Igwe","year":"2017","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.gendis.2021.10.009_bib81","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1182\/blood-2007-09-112920","article-title":"Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95","volume":"111","author":"M\u00f6ricke","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.gendis.2021.10.009_bib82","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ccr.2011.10.012","article-title":"IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development","volume":"20","author":"Reynaud","year":"2011","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.gendis.2021.10.009_bib83","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4149\/neo_2018_180121N44","article-title":"miR-451a induced apoptosis of Philadelphia chromosome-positive acute lymphoblastic leukemia cells by targeting IL-6R","volume":"65","author":"Jiang","year":"2018","journal-title":"Neoplasma"},{"issue":"4","key":"10.1016\/j.gendis.2021.10.009_bib84","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3892\/ijo.2014.2259","article-title":"The IL-6\/JAK\/STAT3 pathway: potential therapeutic strategies in treating colorectal cancer (Review)","volume":"44","author":"Wang","year":"2014","journal-title":"Int J Oncol"},{"key":"10.1016\/j.gendis.2021.10.009_bib85","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coi.2015.02.008","article-title":"The IL-6\/gp130\/STAT3 signaling axis: recent advances towards specific inhibition","volume":"34","author":"Garbers","year":"2015","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"10.1016\/j.gendis.2021.10.009_bib86","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/10245332.2016.1252020","article-title":"Downregulation of miR-451 in Tunisian chronic myeloid leukemia patients: potential implication in imatinib resistance","volume":"22","author":"Soltani","year":"2017","journal-title":"Hematology"},{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib87","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3892\/or.2016.4854","article-title":"miR-126-3p and miR-451a correlate with clinicopathological features of lung adenocarcinoma: the underlying molecular mechanisms","volume":"36","author":"Chen","year":"2016","journal-title":"Oncol Rep"},{"issue":"3","key":"10.1016\/j.gendis.2021.10.009_bib88","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.3892\/mmr.2014.2957","article-title":"MicroRNA-451a is associated with cell proliferation, migration and apoptosis in renal cell carcinoma","volume":"11","author":"Su","year":"2015","journal-title":"Mol Med Rep"},{"issue":"7","key":"10.1016\/j.gendis.2021.10.009_bib89","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.leukres.2011.03.029","article-title":"MicroRNA-451 in chronic myeloid leukemia: miR-451\u2013BCR-ABL regulatory loop?","volume":"35","author":"Lopotov\u00e1","year":"2011","journal-title":"Leuk Res"},{"issue":"9","key":"10.1016\/j.gendis.2021.10.009_bib90","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood-2016-08-692590","article-title":"LGL leukemia: from pathogenesis to treatment","volume":"129","author":"Lamy","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.gendis.2021.10.009_bib91","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1182\/blood.V89.1.256","article-title":"The lymphoproliferative disease of granular lymphocytes: updated criteria for diagnosis","volume":"89","author":"Semenzato","year":"1997","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.gendis.2021.10.009_bib92","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3324\/haematol.2019.225060","article-title":"Identification of a miR-146b-Fas ligand axis in the development of neutropenia in T large granular lymphocyte leukemia","volume":"105","author":"Mariotti","year":"2020","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.gendis.2021.10.009_bib93","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2217\/fon.12.75","article-title":"Large granular lymphocyte leukemia: from dysregulated pathways to therapeutic targets","volume":"8","author":"Leblanc","year":"2012","journal-title":"Future Oncol"},{"issue":"12","key":"10.1016\/j.gendis.2021.10.009_bib94","doi-asserted-by":"crossref","first-page":"7486","DOI":"10.4049\/jimmunol.166.12.7486","article-title":"Cooperative regulation of Mcl-1 by Janus kinase\/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils","volume":"166","author":"Epling-Burnette","year":"2001","journal-title":"J Immunol"},{"issue":"37","key":"10.1016\/j.gendis.2021.10.009_bib95","doi-asserted-by":"crossref","first-page":"61876","DOI":"10.18632\/oncotarget.18711","article-title":"STAT3 mutation impacts biological and clinical features of T-LGL leukemia","volume":"8","author":"Teramo","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.gendis.2021.10.009_bib96","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nm0396-317","article-title":"Fas ligand in human serum","volume":"2","author":"Tanaka","year":"1996","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.gendis.2021.10.009_bib97","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1034\/j.1600-0609.2000.065004272.x","article-title":"Improvement of extrathymic T cell type of large granular lymphocyte (LGL) leukemia by cyclosporin A: the serum level of Fas ligand is a marker of LGL leukemia activity","volume":"65","author":"Saitoh","year":"2000","journal-title":"Eur J Haematol"},{"issue":"10","key":"10.1016\/j.gendis.2021.10.009_bib98","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood.V95.10.3219","article-title":"Chronic neutropenia mediated by fas ligand","volume":"95","author":"Liu","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.gendis.2021.10.009_bib99","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1046\/j.1365-2141.1997.d01-2113.x","article-title":"Constitutive expression of Fas ligand in large granular lymphocyte leukaemia","volume":"97","author":"Perzova","year":"1997","journal-title":"Br J Haematol"},{"issue":"15","key":"10.1016\/j.gendis.2021.10.009_bib100","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood-2012-06-435297","article-title":"STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia","volume":"120","author":"Jerez","year":"2012","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.gendis.2021.10.009_bib101","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.gendis.2021.10.009_bib102","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1158\/0008-5472.CAN-10-3304","article-title":"A requirement of STAT3 DNA binding precludes Th-1 immunostimulatory gene expression by NF-\u03baB in tumors","volume":"71","author":"Lee","year":"2011","journal-title":"Cancer Res"},{"issue":"17","key":"10.1016\/j.gendis.2021.10.009_bib103","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.1128\/MCB.25.17.7432-7440.2005","article-title":"Role of Stat3 in regulating p53 expression and function","volume":"25","author":"Niu","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"310","key":"10.1016\/j.gendis.2021.10.009_bib104","doi-asserted-by":"crossref","first-page":"ra11","DOI":"10.1126\/scisignal.2004497","article-title":"STAT3 induction of miR-146b forms a feedback loop to inhibit the NF-\u03baB to IL-6 signaling axis and STAT3-driven cancer phenotypes","volume":"7","author":"Xiang","year":"2014","journal-title":"Sci Signal"},{"key":"10.1016\/j.gendis.2021.10.009_bib105","doi-asserted-by":"crossref","first-page":"2584940","DOI":"10.1155\/2016\/2584940","article-title":"Differential DNA methylation of microRNA genes in temporal cortex from Alzheimer's disease individuals","volume":"2016","author":"Villela","year":"2016","journal-title":"Neural Plast"},{"issue":"28","key":"10.1016\/j.gendis.2021.10.009_bib106","doi-asserted-by":"crossref","first-page":"11499","DOI":"10.1073\/pnas.1219852110","article-title":"Negative regulation of Toll-like receptor 4 signaling by IL-10\u2013dependent microRNA-146b","volume":"110","author":"Curtale","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gendis.2021.10.009_bib107","doi-asserted-by":"crossref","first-page":"145305","DOI":"10.1155\/2015\/145305","article-title":"MiR-146b mediates endotoxin tolerance in human phagocytes","volume":"2015","author":"Renzi","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"7","key":"10.1016\/j.gendis.2021.10.009_bib108","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/emmm.201202318","article-title":"Micro RNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways","volume":"5","author":"Cheng","year":"2013","journal-title":"EMBO Mol Med"},{"issue":"41","key":"10.1016\/j.gendis.2021.10.009_bib109","doi-asserted-by":"crossref","first-page":"31130","DOI":"10.1074\/jbc.M110.137919","article-title":"FasL expression in activated T lymphocytes involves HuR-mediated stabilization","volume":"285","author":"Drury","year":"2010","journal-title":"J Biol Chem"},{"issue":"27","key":"10.1016\/j.gendis.2021.10.009_bib110","doi-asserted-by":"crossref","first-page":"41505","DOI":"10.18632\/oncotarget.9214","article-title":"MiR-146b-5p overexpression attenuates stemness and radioresistance of glioma stem cells by targeting HuR\/lincRNA-p21\/\u03b2-catenin pathway","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.gendis.2021.10.009_bib111","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ajh.23691","article-title":"Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management","volume":"89","author":"Jabbour","year":"2014","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.gendis.2021.10.009_bib112","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3892\/ol.2015.3842","article-title":"MicroRNA-147 suppresses proliferation, invasion and migration through the AKT\/mTOR signaling pathway in breast cancer","volume":"11","author":"Zhang","year":"2016","journal-title":"Oncol Lett"},{"issue":"12","key":"10.1016\/j.gendis.2021.10.009_bib113","first-page":"2787","article-title":"MicroRNA-147 suppresses human hepatocellular carcinoma proliferation migration and chemosensitivity by inhibiting HOXC6","volume":"6","author":"Sui","year":"2016","journal-title":"Am J Cancer Res"},{"issue":"1","key":"10.1016\/j.gendis.2021.10.009_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084597","article-title":"MicroRNA-147 induces a mesenchymal-to-epithelial transition (MET) and reverses EGFR inhibitor resistance","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.gendis.2021.10.009_bib115","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3109\/1061186X.2015.1116539","article-title":"Serum level of microRNA-147 as diagnostic biomarker in human non-small cell lung cancer","volume":"24","author":"Chu","year":"2016","journal-title":"J Drug Target"},{"issue":"6","key":"10.1016\/j.gendis.2021.10.009_bib116","first-page":"963","article-title":"MicroRNA profiling of human gastric cancer","volume":"2","author":"Yao","year":"2009","journal-title":"Mol Med Rep"},{"issue":"6","key":"10.1016\/j.gendis.2021.10.009_bib117","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1159\/000484452","article-title":"Maternally expressed gene 3 (MEG3) enhances PC12 cell hypoxia injury by targeting MiR-147","volume":"43","author":"Han","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.gendis.2021.10.009_bib118","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ebiom.2018.07.013","article-title":"The long noncoding RNA MEG3 and its target miR-147 regulate JAK\/STAT pathway in advanced chronic myeloid leukemia","volume":"34","author":"Li","year":"2018","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.gendis.2021.10.009_bib119","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3892\/ijo.2011.1294","article-title":"Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines","volume":"40","author":"Tatarano","year":"2012","journal-title":"Int J Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2021.10.009_bib120","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1186\/s12864-015-1899-0","article-title":"Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer","volume":"16","author":"Krishnan","year":"2015","journal-title":"BMC Genomics"},{"issue":"4","key":"10.1016\/j.gendis.2021.10.009_bib121","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.intimp.2012.05.016","article-title":"Aberrant expression of microRNAs in gastric cancer and biological significance of miR-574-3p","volume":"13","author":"Su","year":"2012","journal-title":"Int Immunopharmacol"},{"issue":"6","key":"10.1016\/j.gendis.2021.10.009_bib122","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.3892\/ol.2016.5355","article-title":"miR-574-3p acts as a tumor promoter in osteosarcoma by targeting SMAD4 signaling pathway","volume":"12","author":"Xu","year":"2016","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.gendis.2021.10.009_bib123","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12957-016-0985-3","article-title":"The expression of microRNA 574-3p as a predictor of postoperative outcome in patients with esophageal squamous cell carcinoma","volume":"14","author":"Okumura","year":"2016","journal-title":"World J Surg Oncol"},{"issue":"9","key":"10.1016\/j.gendis.2021.10.009_bib124","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1002\/cncr.22999","article-title":"Interleukin-6 and its receptor in cancer: implications for translational therapeutics","volume":"110","author":"Hong","year":"2007","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.gendis.2021.10.009_bib125","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood-2005-02-0456","article-title":"IL-6 blocks a discrete early step in lymphopoiesis","volume":"106","author":"Maeda","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.gendis.2021.10.009_bib126","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1002\/jcp.23029","article-title":"Imatinib treatment inhibit IL-6, IL-8, NF-KB and AP-1 production and modulate intracellular calcium in CML patients","volume":"227","author":"Ciarcia","year":"2012","journal-title":"J Cell Physiol"},{"issue":"5","key":"10.1016\/j.gendis.2021.10.009_bib127","first-page":"4296","article-title":"Overexpression of miR-574-3p suppresses proliferation and induces apoptosis of chronic myeloid leukemia cells via targeting IL6\/JAK\/STAT3 pathway","volume":"16","author":"Yang","year":"2018","journal-title":"Exp Ther Med"},{"issue":"9861","key":"10.1016\/j.gendis.2021.10.009_bib128","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.gendis.2021.10.009_bib129","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/cpt.2028","article-title":"Changing the clinical paradigm of hydroxyurea treatment for sickle cell anemia through precision medicine","volume":"109","author":"Dong","year":"2021","journal-title":"Clin Pharmacol Ther"},{"issue":"23","key":"10.1016\/j.gendis.2021.10.009_bib130","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.gendis.2021.10.009_bib131","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1177\/1535370216636725","article-title":"Original Research: Stable expression of miR-34a mediates fetal hemoglobin induction in K562 cells","volume":"241","author":"Ward","year":"2016","journal-title":"Exp Biol Med (Maywood)"},{"issue":"11","key":"10.1016\/j.gendis.2021.10.009_bib132","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1073\/pnas.90.11.5039","article-title":"Sparing effect of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S at physiologic ligand saturations","volume":"90","author":"Poillon","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib133","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2141.2007.06794.x","article-title":"Sickle-cell haemoglobin polymerization: is it the primary pathogenic event of sickle-cell anaemia?","volume":"139","author":"Vekilov","year":"2007","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.gendis.2021.10.009_bib134","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.3892\/or.2014.3005","article-title":"YY1-C\/EBP\u03b1-miR34a regulatory circuitry is involved in renal cell carcinoma progression","volume":"31","author":"Weng","year":"2014","journal-title":"Oncol Rep"},{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib135","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1021\/pr1006697","article-title":"Systematic proteome analysis identifies transcription factor YY1 as a direct target of miR-34a","volume":"10","author":"Chen","year":"2011","journal-title":"J Proteome Res"},{"issue":"9","key":"10.1016\/j.gendis.2021.10.009_bib136","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/mt.2013.148","article-title":"TP53-independent function of miR-34a via HDAC1 and p21(CIP1\/WAF1.)","volume":"21","author":"Zhao","year":"2013","journal-title":"Mol Ther"},{"issue":"11","key":"10.1016\/j.gendis.2021.10.009_bib137","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002363","article-title":"Capture of microRNA\u2013bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling","volume":"7","author":"Lal","year":"2011","journal-title":"PLoS Genet"},{"issue":"8","key":"10.1016\/j.gendis.2021.10.009_bib138","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.exphem.2009.05.004","article-title":"Role of STAT3 and GATA-1 interactions in gamma-globin gene expression","volume":"37","author":"Yao","year":"2009","journal-title":"Exp Hematol"},{"issue":"5","key":"10.1016\/j.gendis.2021.10.009_bib139","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0301-472X(03)00045-6","article-title":"Erythropoietin-induced serine 727 phosphorylation of STAT3 in erythroid cells is mediated by a MEK-, ERK-, and MSK1-dependent pathway","volume":"31","author":"Wierenga","year":"2003","journal-title":"Exp Hematol"},{"issue":"7","key":"10.1016\/j.gendis.2021.10.009_bib140","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1038\/bcj.2016.50","article-title":"Acute myeloid leukemia: a comprehensive review and 2016 update","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J"},{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib141","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/bjh.12772","article-title":"Thrombopoietin from beginning to end","volume":"165","author":"Hitchcock","year":"2014","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib142","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1182\/blood.V89.2.483","article-title":"Thrombopoietin signal transduction in purified murine megakaryocytes","volume":"89","author":"Drachman","year":"1997","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.gendis.2021.10.009_bib143","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1182\/blood-2013-12-544197","article-title":"miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155\/JARID2 axis in abnormal megakaryopoiesis","volume":"124","author":"Norfo","year":"2014","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.gendis.2021.10.009_bib144","doi-asserted-by":"crossref","first-page":"21380","DOI":"10.18632\/oncotarget.15226","article-title":"miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem\/progenitor cells by targeting SOCS6","volume":"8","author":"Rontauroli","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.gendis.2021.10.009_bib145","first-page":"2115","article-title":"MiRNA-155 mediates TAM resistance by modulating SOCS6-STAT3 signalling pathway in breast cancer","volume":"7","author":"Shen","year":"2015","journal-title":"Am J Transl Res"},{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib146","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bbrc.2007.06.062","article-title":"The nuclear localization of SOCS6 requires the N-terminal region and negatively regulates Stat3 protein levels","volume":"360","author":"Hwang","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.gendis.2021.10.009_bib147","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00000421-199802000-00010","article-title":"The erythroid leukemias: a comparative study of erythroleukemia (FAB M6) and Di Guglielmo disease","volume":"21","author":"Goldberg","year":"1998","journal-title":"Am J Clin Oncol"},{"issue":"8","key":"10.1016\/j.gendis.2021.10.009_bib148","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/jcp.54.8.608","article-title":"Erythroleukaemia in the north of England: a population based study","volume":"54","author":"Wells","year":"2001","journal-title":"J Clin Pathol"},{"issue":"10","key":"10.1016\/j.gendis.2021.10.009_bib149","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1182\/blood-2009-09-243964","article-title":"Acute erythroid leukemia: a reassessment using criteria refined in the 2008 WHO classification","volume":"115","author":"Hasserjian","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.gendis.2021.10.009_bib150","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1038\/leu.2009.181","article-title":"Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution","volume":"23","author":"Santos","year":"2009","journal-title":"Leukemia"},{"issue":"38","key":"10.1016\/j.gendis.2021.10.009_bib151","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1038\/onc.2009.202","article-title":"Stat3 promotes the development of erythroleukemia by inducing Pu. 1 expression and inhibiting erythroid differentiation","volume":"28","author":"Hegde","year":"2009","journal-title":"Oncogene"},{"issue":"46","key":"10.1016\/j.gendis.2021.10.009_bib152","doi-asserted-by":"crossref","first-page":"6001","DOI":"10.1038\/onc.2016.127","article-title":"microRNA-23a,-27a and-24 synergistically regulate JAK1\/Stat3 cascade and serve as novel therapeutic targets in human acute erythroid leukemia","volume":"35","author":"Su","year":"2016","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.gendis.2021.10.009_bib153","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1179\/102453311X13025568941925","article-title":"Inhibition of Stat3 expression induces apoptosis and suppresses proliferation in human leukemia HL-60 cells","volume":"16","author":"Zhao","year":"2011","journal-title":"Hematology"},{"issue":"3","key":"10.1016\/j.gendis.2021.10.009_bib154","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1172\/JCI9940","article-title":"Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression","volume":"107","author":"Epling-Burnette","year":"2001","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.gendis.2021.10.009_bib155","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.leukres.2014.07.004","article-title":"LIFR\u03b1-CT3 induces differentiation of a human acute myelogenous leukemia cell line HL-60 by suppressing miR-155 expression through the JAK\/STAT pathway","volume":"38","author":"Xu","year":"2014","journal-title":"Leuk Res"},{"issue":"5","key":"10.1016\/j.gendis.2021.10.009_bib156","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1590\/S0100-879X2007000500004","article-title":"TIMP-1 mediates the inhibitory effect of interleukin-6 on the proliferation of a hepatocarcinoma cell line in a STAT3-dependent manner","volume":"40","author":"Guo","year":"2007","journal-title":"Braz J Med Biol Res"},{"issue":"4","key":"10.1016\/j.gendis.2021.10.009_bib157","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.3892\/ijo.2015.2851","article-title":"The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells","volume":"46","author":"Ying","year":"2015","journal-title":"Int J Oncol"},{"issue":"1\u20132","key":"10.1016\/j.gendis.2021.10.009_bib158","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neulet.2011.02.006","article-title":"Stage-dependent STAT3 activation is involved in the differentiation of rat hippocampus neural stem cells","volume":"493","author":"Cheng","year":"2011","journal-title":"Neurosci Lett"},{"issue":"21","key":"10.1016\/j.gendis.2021.10.009_bib159","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.3390\/ijms20215273","article-title":"Interleukin-6 induces myogenic differentiation via JAK2-STAT3 signaling in mouse C2C12 myoblast cell line and primary human myoblasts","volume":"20","author":"Steyn","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"14","key":"10.1016\/j.gendis.2021.10.009_bib160","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1002\/j.1460-2075.1996.tb00734.x","article-title":"A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells","volume":"15","author":"Nakajima","year":"1996","journal-title":"EMBO J"},{"issue":"14","key":"10.1016\/j.gendis.2021.10.009_bib161","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.3889\/oamjms.2019.589","article-title":"IL-6 activities in the tumour microenvironment. Part 1","volume":"7","author":"Chonov","year":"2019","journal-title":"Open Access Maced J Med Sci"},{"key":"10.1016\/j.gendis.2021.10.009_bib162","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1146\/annurev.immunol.15.1.797","article-title":"Gp130 and the interleukin-6 family of cytokines","volume":"15","author":"Taga","year":"1997","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib163","first-page":"399","article-title":"Free LIF receptor \u03b1-chain distal cytoplasmic motifs enhance Jak2-independent STAT3 phosphorylation and induce differentiation in HL-60 cells","volume":"26","author":"Sun","year":"2011","journal-title":"Oncol Rep"},{"issue":"9","key":"10.1016\/j.gendis.2021.10.009_bib164","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific microRNAs from mouse","volume":"12","author":"Lagos-Quintana","year":"2002","journal-title":"Curr Biol"},{"issue":"10","key":"10.1016\/j.gendis.2021.10.009_bib165","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1182\/blood-2008-01-133355","article-title":"MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia","volume":"111","author":"Jongen-Lavrencic","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.gendis.2021.10.009_bib166","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1182\/blood-2010-09-191312","article-title":"The prognostic and functional role of microRNAs in acute myeloid leukemia","volume":"117","author":"Marcucci","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.gendis.2021.10.009_bib167","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood-2007-07-098749","article-title":"MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia","volume":"111","author":"Garzon","year":"2008","journal-title":"Blood"},{"issue":"27","key":"10.1016\/j.gendis.2021.10.009_bib168","doi-asserted-by":"crossref","first-page":"20492","DOI":"10.1074\/jbc.M110.102111","article-title":"IL-10 inhibits miR-155 induction by toll-like receptors","volume":"285","author":"McCoy","year":"2010","journal-title":"J Biol Chem"},{"issue":"6636","key":"10.1016\/j.gendis.2021.10.009_bib169","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/43206","article-title":"A family of cytokine-inducible inhibitors of signalling","volume":"387","author":"Starr","year":"1997","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.gendis.2021.10.009_bib170","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1056\/NEJMra1011165","article-title":"Oxygen sensing, homeostasis, and disease","volume":"365","author":"Semenza","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gendis.2021.10.009_bib171","article-title":"Under hypoxic conditions, MSCs affect the expression and methylation level of survival-related genes in ALL independent of apoptosis pathways in vitro","author":"Marofi","year":"2021","journal-title":"Biotechnol Appl Biochem"},{"issue":"5","key":"10.1016\/j.gendis.2021.10.009_bib172","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.gendis.2021.10.009_bib173","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/sj.leu.2403141","article-title":"Cobalt chloride and low oxygen tension trigger differentiation of acute myeloid leukemic cells: possible mediation of hypoxia-inducible factor-1alpha","volume":"17","author":"Huang","year":"2003","journal-title":"Leukemia"},{"issue":"42","key":"10.1016\/j.gendis.2021.10.009_bib174","doi-asserted-by":"crossref","first-page":"36808","DOI":"10.1074\/jbc.M111.247262","article-title":"Synergistic induction of galectin-1 by CCAAT\/enhancer binding protein \u03b1 and hypoxia-inducible factor 1\u03b1 and its role in differentiation of acute myeloid leukemic cells","volume":"286","author":"Zhao","year":"2011","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.gendis.2021.10.009_bib175","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/cdd.2012.130","article-title":"HIF-1\u03b1 downregulates miR-17\/20a directly targeting p21 and STAT3: a role in myeloid leukemic cell differentiation","volume":"20","author":"He","year":"2013","journal-title":"Cell Death Differ"},{"issue":"1\u20132","key":"10.1016\/j.gendis.2021.10.009_bib176","first-page":"36","article-title":"Effects of Tiron, 4, 5-dihydroxy-1, 3-benzene disulfonic acid, on human promyelotic HL-60 leukemia cell differentiation and death","volume":"223","author":"Kim","year":"2006","journal-title":"Toxicology"},{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib177","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1182\/blood-2005-03-1278","article-title":"Induction of tumor arrest and differentiation with prolonged survival by intermittent hypoxia in a mouse model of acute myeloid leukemia","volume":"107","author":"Liu","year":"2006","journal-title":"Blood"},{"issue":"35","key":"10.1016\/j.gendis.2021.10.009_bib178","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1038\/sj.onc.1209503","article-title":"Functional analyses of the TEL-ARNT fusion protein underscores a role for oxygen tension in hematopoietic cellular differentiation","volume":"25","author":"Nguyen-Khac","year":"2006","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.gendis.2021.10.009_bib179","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/sj.onc.1210670","article-title":"Hypoxia-inducible factor-1alpha-induced differentiation of myeloid leukemic cells is its transcriptional activity independent","volume":"27","author":"Song","year":"2008","journal-title":"Oncogene"},{"issue":"21","key":"10.1016\/j.gendis.2021.10.009_bib180","doi-asserted-by":"crossref","first-page":"9628","DOI":"10.1158\/0008-5472.CAN-05-2352","article-title":"A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation","volume":"65","author":"Hayashita","year":"2005","journal-title":"Cancer Res"},{"issue":"7043","key":"10.1016\/j.gendis.2021.10.009_bib181","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/nature03552","article-title":"A microRNA polycistron as a potential human oncogene","volume":"435","author":"He","year":"2005","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.gendis.2021.10.009_bib182","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"10.1016\/j.gendis.2021.10.009_bib183","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1158\/0008-5472.CAN-07-6460","article-title":"Identification of hypoxia-inducible factor-1\u03b1 as a novel target for miR-17-92 microRNA cluster","volume":"68","author":"Taguchi","year":"2008","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.gendis.2021.10.009_bib184","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1172\/JCI42980","article-title":"Hypoxia-induced microRNA-424 expression in human endothelial cells regulates HIF-\u03b1 isoforms and promotes angiogenesis","volume":"120","author":"Ghosh","year":"2010","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.gendis.2021.10.009_bib185","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jcp.22126","article-title":"miR-20b modulates VEGF expression by targeting HIF-1\u03b1 and STAT3 in MCF-7 breast cancer cells","volume":"224","author":"Cascio","year":"2010","journal-title":"J Cell Physiol"},{"issue":"6","key":"10.1016\/j.gendis.2021.10.009_bib186","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrc2657","article-title":"p21 in cancer: intricate networks and multiple activities","volume":"9","author":"Abbas","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"10.1016\/j.gendis.2021.10.009_bib187","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4049\/jimmunol.178.5.2623","article-title":"The JAK-STAT signaling pathway: input and output integration","volume":"178","author":"Murray","year":"2007","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.gendis.2021.10.009_bib188","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00277-019-03637-7","article-title":"Acute myeloid leukemia with t (8; 16)(p11. 2; p13. 3)\/KAT6A-CREBBP in adults","volume":"98","author":"Xie","year":"2019","journal-title":"Ann Hematol"},{"issue":"3","key":"10.1016\/j.gendis.2021.10.009_bib189","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/leu.2012.278","article-title":"Acute myeloid leukemia with translocation (8; 16)(p11; p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene","volume":"27","author":"D\u00edaz-Bey\u00e1","year":"2013","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.gendis.2021.10.009_bib190","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neo.2018.12.005","article-title":"MicroRNA-503-5p inhibits the CD97-mediated JAK2\/STAT3 pathway in metastatic or paclitaxel-resistant ovarian cancer cells","volume":"21","author":"Park","year":"2019","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.gendis.2021.10.009_bib191","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1158\/1078-0432.CCR-17-2485","article-title":"Clinical utility of a STAT3-regulated miRNA-200 family signature with prognostic potential in early gastric cancer","volume":"24","author":"Yu","year":"2018","journal-title":"Clin Cancer Res."},{"issue":"8","key":"10.1016\/j.gendis.2021.10.009_bib192","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1158\/0008-5472.CAN-16-1115","article-title":"The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer.","volume":"77","author":"Chen","year":"2017","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.gendis.2021.10.009_bib193","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1172\/JCI73531","article-title":"IL-6R\/STAT3\/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.","volume":"124","author":"Rokavec","year":"2014","journal-title":"J Clin Investig."},{"issue":"4","key":"10.1016\/j.gendis.2021.10.009_bib194","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/carcin\/bgz121","article-title":"MicroRNA-301a promotes pancreatic cancer invasion and metastasis through the JAK\/STAT3 signaling pathway by targeting SOCS5","volume":"41","author":"Hu","year":"2020","journal-title":"J Carcinog."},{"issue":"5","key":"10.1016\/j.gendis.2021.10.009_bib195","first-page":"5017","article-title":"MicroRNA-204 targets JAK2 in breast cancer and induces cell apoptosis through the STAT3\/BCl-2\/survivin pathway","volume":"8","author":"Wang","year":"2015","journal-title":"Int J Clin Exp Pathol."},{"key":"10.1016\/j.gendis.2021.10.009_bib196","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.biopha.2016.09.074","article-title":"miRNA-133b and miRNA-135a induce apoptosis via the JAK2\/STAT3 signaling pathway in human renal carcinoma cells.","volume":"84","author":"Zhou","year":"2016","journal-title":"Biomed Pharmacother."},{"issue":"1","key":"10.1016\/j.gendis.2021.10.009_bib197","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.canlet.2014.01.020","article-title":"MicroRNA let-7 downregulates STAT3 phosphorylation in pancreatic cancer cells by increasing SOCS3 expression.","volume":"347","author":"Patel","year":"2014","journal-title":"Cancer Lett"},{"key":"10.1016\/j.gendis.2021.10.009_bib198","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2019.12.038","article-title":"Natural killer T cell cytotoxic activity in cervical cancer is facilitated by the LINC00240\/microRNA-124-3p\/STAT3\/MICA axis.","volume":"474","author":"Zhang","year":"2020","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.gendis.2021.10.009_bib199","first-page":"143","article-title":"STAT3 regulation of and by microRNAs in development and disease","volume":"1","author":"Haghikia","year":"2012","journal-title":"JAKSTAT"},{"key":"10.1016\/j.gendis.2021.10.009_bib200","doi-asserted-by":"crossref","first-page":"101442","DOI":"10.1016\/j.mcp.2019.101442","article-title":"Differential expression of miRNAs regulating NF-\u03baB and STAT3 crosstalk during colitis-associated tumorigenesis","volume":"47","author":"El-Daly SM","year":"2019","journal-title":"Mol Cell Probes"},{"issue":"48","key":"10.1016\/j.gendis.2021.10.009_bib201","doi-asserted-by":"crossref","first-page":"79805","DOI":"10.18632\/oncotarget.12972","article-title":"MicroRNA-206 attenuates the growth and angiogenesis in non-small cell lung cancer cells by blocking the 14-3-3\u03b6\/STAT3\/HIF-1\u03b1\/VEGF signaling.","volume":"7","author":"Xue","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.gendis.2021.10.009_bib202","doi-asserted-by":"crossref","first-page":"16633","DOI":"10.18632\/oncotarget.15114","article-title":"microRNA-375 inhibits colorectal cancer cells proliferation by downregulating JAK2\/STAT3 and MAP3K8\/ERK signaling pathways","volume":"8","author":"Wei","year":"2017","journal-title":"Oncotarget"},{"issue":"51","key":"10.1016\/j.gendis.2021.10.009_bib203","doi-asserted-by":"crossref","first-page":"88870","DOI":"10.18632\/oncotarget.21488","article-title":"MicroRNA-216a inhibits the metastasis of gastric cancer cells by targeting JAK2\/STAT3-mediated EMT process.","volume":"8","author":"Tao","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.gendis.2021.10.009_bib204","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.3892\/or.2017.5947","article-title":"miRNA\u2011148a inhibits cell growth of papillary thyroid cancer through STAT3 and PI3K\/AKT signaling pathways.","volume":"38","author":"Xu","year":"2017","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.gendis.2021.10.009_bib205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-017-0710-z","article-title":"MicroRNA-218 functions as a tumor suppressor in lung cancer by targeting IL-6\/STAT3 and negatively correlates with poor prognosis","volume":"16","author":"Yang Y","year":"2017","journal-title":"Mol Cancer"},{"key":"10.1016\/j.gendis.2021.10.009_bib206","first-page":"90","article-title":"Identification of a miR-146b-FasL axis in the development of neutropenia in T large granular lymphocyte leukemia.","volume":"49","author":"Mariotti","year":"2019","journal-title":"Haematologica."}],"container-title":["Genes &amp; Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304221001574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304221001574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T17:28:08Z","timestamp":1762450088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304221001574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":206,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2352304221001574"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2021.10.009","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNAs and JAK\/STAT3 signaling: A new promising therapeutic axis in blood cancers","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2021.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Chongqing Medical University. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}